Example: Heart Attack

Clinical Trials on Giant Cell Tumors

Total 278 results

NCT02948088

Active, not recruiting

Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project

Conditions: Giant Cell Tumors
NCT04703322

Not yet recruiting

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Conditions: Tenosynovial Giant Cell Tumor
NCT04526704

Recruiting

Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib

Conditions: Tenosynovial Giant Cell Tumor
NCT04586660

Not yet recruiting

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Conditions: Giant Cell Tumor of Bone
NCT03358212

Not yet recruiting

Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China

Conditions: Giant Cell Tumor of Bone
NCT04002817

Completed

Giant Cell Tumor of the Bone in Young Patients

Conditions: Giant Cell Tumor of Bone
NCT03259152

Unknown status

Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone

Conditions: Giant Cell Tumor of Bone
NCT04255576

Not yet recruiting

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Conditions: Giant Cell Tumor of Bone
NCT03301857

Active, not recruiting

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

Conditions: Giant Cell Tumor of Bone
NCT03295981

Recruiting

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Conditions: Giant Cell Tumor of Bone
NCT03620149

Terminated

Reduced Dose-density of Denosumab for Unresectable GCTB

Conditions: Bone Giant Cell Tumor
NCT01564121

Terminated

Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa

Conditions: Giant Cell Tumors of Bone
NCT02471716

Completed

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

Conditions: Pigmented Villonodular Synovitis; Tenosynovial Giant Cell Tumor
NCT04488822

Recruiting

A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT

Conditions: Tenosynovial Giant Cell Tumor
NCT00396279

Completed

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Conditions: GCT; Giant Cell Tumor of Bone
NCT04731675

Not yet recruiting

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Conditions: Tenosynovial Giant Cell Tumor; Pigmented Villonodular Synovitis
NCT02996734

Completed

Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment

Conditions: Giant Cell Tumor of Bone
NCT00889590

Terminated

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)

Conditions: Giant Cell Tumor of Bone; Osteoclastoma
NCT00680992

Completed

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Conditions: Cancer; Giant Cell Tumors; Giant Cell Tumor of Bone; Benign Giant Cell Tumors
NCT02371369

Active, not recruiting

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Conditions: Pigmented Villonodular Synovitis; Giant Cell Tumors of the Tendon Sheath; Tenosynovial Giant Cell Tumor
NCT01207492

Active, not recruiting

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Conditions: Pigmented Villonodular Synovitis; Diffuse-type Giant Cell Tumor; Tenosynovial Giant Cell Tumor
NCT02673736

Terminated

A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Conditions: Solid Tumors; Tenosynovial Giant Cell Tumor; Synovitis, Pigmented Villonodular
NCT03069469

Recruiting

Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Conditions: Advanced Malignant Neoplasm; Pigmented Villonodular Synovitis; Giant Cell Tumor of Tendon Sheath; Tenosynovial Giant Cell Tumor; Tenosynovial Giant Cell Tumor, Diffuse
NCT04635111

Recruiting

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Conditions: Hepatotoxicity; Tenosynovial Giant Cell Tumor
NCT01261429

Completed

Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)

Conditions: Pigmented Villonodular Synovitis